Related Experiment Video

Updated: Jun 12, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

[Unexpected failure of antioxidant clinical trials]

Tomasz H Wierzba1

  • 1Katedra i Zakład Fizjologii, Akademia Medyczna, Gdańsk. twierzba@amg.gda.pl

Kardiologia Polska
|June 10, 2010
PubMed

Insights

Antioxidant supplements show benefits in lab studies but fail to prove effective in human trials. Further research is needed to understand how antioxidants impact the body and potentially disrupt its balance.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Physiology

Context:

  • Experimental studies suggest antioxidant benefits.
  • Clinical trials and meta-analyses show a lack of proven benefits.
  • Focus on reactive oxygen species (ROS) and antioxidant interactions.

Purpose:

  • To reconcile conflicting data on antioxidant supplementation.
  • To explore mechanisms by which antioxidants may disrupt physiological functions.
  • To analyze the regulatory aspects of ROS and antioxidant-induced homeostasis disturbances.

Summary:

  • Contrasts experimental findings with clinical trial outcomes for antioxidant supplementation.
  • Investigates potential mechanisms of disruption for physiological functions by antioxidants.
  • Examines the regulatory roles of ROS and how antioxidants interfere with homeostasis.

Impact:

  • Highlights the discrepancy between in vitro and in vivo antioxidant effects.
  • Suggests a need for revised research directions in antioxidant therapy.
  • Provides insights into the complex biological roles of reactive oxygen species.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...